Abstract PO4-09-11: Predictors of cardiotoxicity in early breast cancer patients treated with Doxorubicin and/or Trastuzumab: Implications of race/ethnicity and insurance status

Authors

Shahzaad Jahangier, Advocate Health - MidwestFollow
Rubina Qamar, Advocate Health - MidwestFollow
Vinay Thohan, Advocate Health - Midwest
Maharaj Singh, Advocate Health - Midwest
Yunqi Liao, Advocate Health - MidwestFollow
James Weese, Advocate Health - MidwestFollow
Bijoy Khandheria, Advocate Health - Midwest
Anna Kamke-Jordan, Advocate Health - MidwestFollow

Recommended Citation

Jahangier S, Qamar R, Thohan V, et al. Abstract PO4-09-11: Predictors of Cardiotoxicity in Early Breast Cancer Patients Treated with Doxorubicin and/or Trastuzumab: Implications of Race/Ethnicity and Insurance Status. Cancer Research. 2024;84(9_Supplement):PO4-09-11-PO4-09-11. doi:10.1158/1538-7445.SABCS23-PO4-09-11

Type

Abstract